• Editorial •
Breast MR imaging for the individual treatment of patient with breast cancer
DOI:10.3969/j.issn.1674-8034.2011.03.005.
| [Abstract] It has been shown that MR imaging of the breast can fill many of the clinical information gaps that are inadequately evaluated by current conventional mammography and sonography due to MRI’s inherently high soft-tissue contrast and no ionising radiation. The usefulness of breast MRI in the individual treatment of patient with breast cancer was discussed in the paper, including cancer staging, detecting the primary malignancy of patients presenting as axillary metastases, screening the contralateral breast for occult cancer for patients with a finding of cancer in one breast, and MRI-guided localization and biopsy procedures. |
| [Keywords] MR imaging；Breast；Breast cancer；Individual treatment |
LIU Pei-fang* Department of Breast Imaging, Cancer Institute & Hospital of Tianjin Medical University, Key Laboratory of Breast Cancer Provention and Therapy of Education Ministry, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
BAO Run-xian Department of Breast Imaging, Cancer Institute & Hospital of Tianjin Medical University, Key Laboratory of Breast Cancer Provention and Therapy of Education Ministry, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
*Correspondence to: Liu PF, E-mail: cjr.liupeifang@vip.163.com
Conflicts of interest None.
| Received 2011-03-21 |
| Accepted 2011-04-28 |
| DOI: 10.3969/j.issn.1674-8034.2011.03.005 |
| DOI:10.3969/j.issn.1674-8034.2011.03.005. |
[1]
Brennan M, Spillane A, Houssami N. The role of breast MRI in clinical practice. Aust Fam Phsician, 2009, 38(7):513-519.
[2]
Gutierrez RL, DeMartini WB, Silbergeld JJ, et al. High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging. AJR Am J Roentgenol, 2011, 196(1):93-99.
[3]
Uematsu T, Kasami M, Yuen S. Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy. Eur Radiol, 2010, 20(10):2315-2322.
[4]
Biglia N, Bounous VE, Martincich L, et al. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. Eur J Surg Oncol, 2011, 37(3):199-204.
[5]
Baron PL, Moore MP, Kinne DW, et al. Occult breast cancer presenting with axillary metastases: Updated management. Arch Surg, 1990, 125(2):210-214.
[6]
Khandelwal AK, Garguilo GA. Therapeutic options for occult breast cancer-a survey of the American Society of Breast Surgeons and review of the literature. Am J Surg, 2005, 190(4):609-613.
[7]
Ko EY, Han BK, Shin JH, et al. Breast MRI evaluating patients with metastatic axillary lymph. Korean J Radiol, 2007, 8(5):382-389.
[8]
Buchanan CL, Morris EA, Dorn PL, et al. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol, 2005, 12(12):1045-1053.
[9]
Lieberman S, Sella T, Maly B, et al. Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma. Isr Med Assoc J, 2008, 10(6):448-452.
[10]
李小康,徐熠琳,刘佩芳,等.乳腺MRI在X线检查乳腺阴性腋淋巴结转移癌阳性患者中的应用价值.中华放射学杂志, 2011, 45(4):348-352.
[11]
Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology, 2004, 233(3):830-849.
[12]
Macura KJ, Ouwerkerk R, Jacobs MA, et al. Patterns of enhancement on breast MR images: interpretation and imaging pitfalls. Radiographics, 2006, 26(6):1719-1734.
[13]
Rausch DR, Hendrick RE. How to optimize clinical breast MR imaging practices and techniques on your 1.5-T system. Radiographics, 2006, 26(5):1469-1484.
[14]
Deurloo EE, Klein Zeggelink WF, Teertstra HJ, et al. Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol, 2006, 16 (3):692-701.
[15]
顾雅佳,汪晓红,肖勤,等.乳腺导管原位癌及其微浸润的磁共振成像评价.中华放射学杂志, 2007, 41(3):248-253.
[16]
Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet, 2007, 370(9586):485-492.
[17]
Federica P，Carlo C, Antonella R, et al. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with X-ray mammography and whole-breast ultrasound. Invest Radiol, 2009, 44(7):412-421.
[18]
Hlawatsch A, Teifke A, SchmidtM, et, al. Preoperative assessment of breast cancer: Sonography versus MR imaging. AJR Am J Roentgenol, 2002, 179(6):1493-1501.
[19]
Schelfout K, Van Goethem M, Kersschot E, et, al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol, 2004, 30(5):501-507.
[20]
Tillman GF, Orel SG, Schnall MD, et al. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol, 2002, 20(16):3413-3423.
[21]
Fischer U, Zachariae O, Baum F, et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol, 2004, 14(10):1725-1731.
[22]
Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet, 2010, 375(9714):563-571.
[23]
Morakkabati N, Leutner CC, Schmiedel A, et al. Breast MR imaging during or soon after radiation therapy. Radiology, 2003, 229(3):893-901.
[24]
Heron DE, Komarnicky LT, Hyslop T, et al. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer, 2000, 88(12):2739-2750.
[25]
Slanetz PJ, Edmister WB, Yeh ED, et al. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J, 2002, 8:145-148.
[26]
Lehman CD, Gatsonis C, Kuhl CK, et al. MRI Evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med, 2007, 356(13):1295-1303.
[27]
Saslow D, Boetes C, Burke W, et al. American Cancer Society Breast Cancer Advisory Group. American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin, 2007, 57(2):75-89.
